'Superbug' Firm Gets Ch. 11 Sale OK'd, Will Sell More Assets
A Delaware judge gave his nod Tuesday to superbug-fighting pharmaceutical company Achaogen's Chapter 11 sale of some equipment and a tentative OK to sell an antibody program, as the more lucrative...To view the full article, register now.
Already a subscriber? Click here to view full article